MarketsandMarkets

BioGeNe Series 2023

8th - 9th February 2023

Double Tree by Hilton, San Diego - Mission Valley

Avail Your Ticket Avail
Your Ticket
Become A Sponsor Become
A Sponsor
Become A Speaker Become
A Speaker

EVENT OVERVIEW

Third Series of BioGeNe

MarketsandMarkets is here with a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2023 Confex on the 8th - 9th February 2023 in San Diego-USA to discuss advancements and solutions to the most critical challenges in the Biomarker, Microbiome and Genome engineering areas.

Tag Line
Biomarker and Companion Diagnostics Immuno-Oncology Cancer Biomarkers Biomarker discovery/ development Translational research Clinical Biomarker Biomarkers in IO and Neurological disorders Imaging Biomarkers Pathology Companion Diagnostics
Tag Line
Next Gen Microbiome and Probiotics Microbiome discovery Department of Biochemistry and Immunology Microbiome science Microbiology Biological Science Gut Biology Human microbiome Drug discovery Therapeutics
Tag Line

Drug discovery businesses have begun to invest in cutting-edge methods for biomarker discovery because of mounting demands related to the success rates of FDA-approved biomarkers and associated diagnostic tests. Speakers are to discuss about Biomarker and Companion Diagnostics and Microbiome and Probiotics. In the past year, the genome editing sector has seen some impressive advancements in the fields of genome writing, base editing, and specific advancements in the treatments using Car-T cells and immunotherapy. Numerous small innovative businesses are present in the market because of the growing emphasis on the development of probiotics products and drugs as well as human microbiome therapies.

The two conferences which are going to be a part of BioGeNe Confex 2023 are, 8th Annual MarketsandMarkets Biomarker and Companion Diagnostics and 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics .

CO-LOCATED CONFERENCES

8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference
5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference

WHAT TO EXPECT

  • Commercialization of CDx
  • Proteomics and Genomics based Biomarkers
  • Biomarker Drug Discovery and Assay Development
  • Effective Microbiome Therapeutics in Production
  • Role of human skin microbiome in precision health
  • The increasing pro bacterial beauty industry
  • Business collaborations- Regulations and Investments
  • Novel horizons in biomarker strategies,
  • Liquid biopsy-based disease detection
  • Current Multi Omics analysis
  • Artificial Intelligence and Machine Learning
  • Gene expression Profiling in Precision Medicine
  • Multiplex Companion Diagnostics and Regulatory Guidelines
  • Design of clinical trials in CDx
  • Microbiome as a science and its clinical applications- skin, gut & women’s health
  • Prebiotics, Probiotics and Postbiotics

  • To share and exchange the recent trends and techniques in Personalized Medicine
  • Quality insights and cohesiveness of key issues and obstacles experienced by the healthcare providers while implementing Precision Medicine
  • Discover the different avenues in patient centric care
  • Access wide range of novel applications, innovative research, regulatory and policy development
  • Opportunity for one-on-one networking and extend professional competency with experts ranging from Government, Industry, Technology, Research and Healthcare providers
  • Be a part of the conversations via panel discussion with great lineup of experts

Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:

Biomarker discovery/development, Translational research, Clinical Biomarker, Biomarkers in IO and Neurological disorders, Imaging Biomarkers, Pathology, Companion Diagnostics, Biomarker Imaging, Proteomics Biomarkers, Experimental Medicine, Data Science. Microbiome discovery, Department of Biochemistry and Immunology, Microbiome science, Microbiology, Biological Science, Gut Biology, Human microbiome, Drug discovery, Therapeutics, Immunotherapy

Industry: Pharma/Therapeutic Companies/Start Up’s

CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Immunologists, Geneticists, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.

Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology

Academics: Universities, Research Institutes, Hospitals

Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians

Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology

Expression #1 of SELECT list is not in GROUP BY clause and contains nonaggregated column 'cnceventswithcrm.s.id' which is not functionally dependent on columns in GROUP BY clause; this is incompatible with sql_mode=only_full_group_by